Molecular docking analysis of shatavarins with female hormonal receptors.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Safety and efficacy of Shatavari in women with low libido: a randomized, double-blind, placebo-controlled trial.Journal of medicine and life · 2026
   Trial
2. Efficacy and safety of Shatavari root extract (Frontiers in reproductive health · 2025
   Trial
3. Unraveling the Mechanistic Insights ofNutrients · 2026
   Review
4. Is Follicle-Stimulating Hormone (FSH) Misnamed? Rethinking Its Role in Menopause as a Systemic Regulator of Bone, Brain, Metabolism, and Aging.Journal of clinical medicine · 2026
   Review
5. Asparagus racemosus Root Extract (SheVari4®) Alleviates Menopausal Symptoms in Pre-, Peri-, and Post-menopausal Healthy Women.Cureus · 2026
   Article
6. SheVari4Food & nutrition research · 2026
   Article
7. Shatavari (Asparagus racemosus): A Promising Ally for Fertility.Current nutrition reports · 2025
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as